CME activity

YJCGH52398S1542-3565(11)00048-610.1016/j.cgh.2011.01.008S1542-3565(10)01188-210.1016/j.cgh.2010.11.008CME

CME activity

Exam 1: Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma

C. MelWilcoxMDEditor, CME Section

CME Credits

The American Gastroenterological Association (AGA) Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The AGA Institute designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure

In accordance with the Accreditation Council for Continuing Medical Education's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any relevant financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Instructions

Category 1 credit can be earned by reading the relevant articles and taking these CME examinations online at http://www.cghjournal.org/content/cme. Answers can be obtained online after completing the exam(s).

Objectives

See article for specific learning objective.

Exam 1: Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma

Test ID No.: 0125

Contact Hours: 1.0

Expiration Date: March 31, 2012

Question 1

While prior studies have shown an increased rate of esophageal cancer in patients with Barrett's esophagus, the number of patients with progression through dysplasia to cancer is widely variable. Such rates per year in the literature vary from:

[a]
0%–1%
[b]
0.2%–3.5%
[c]
3%–5%
[d]
3.5%–8%

Question 2

Which of the following was the only statistically significant predictor of histologic progression to dysplasia or cancer?

[a]
Race
[b]
Age
[c]
Severity of heartburn
[d]
Length of Barrett's esophagus
[e]
Gender

Question 3

In the study by Wani et al, the incident rate for development of esophageal adenocarcinoma was:

[a]
0%
[b]
2.7%
[c]
3.48%
[d]
0.78%

Question 4

In the study by Wani et al, the incident rate for low-grade dysplasia per year was:

[a]
0.2%
[b]
0.38%
[c]
0.21%
[d]
3.6%

YJCGH52399S1542-3565(11)00049-810.1016/j.cgh.2011.01.009S1542-3565(10)01028-110.1016/j.cgh.2010.10.015CME

CME activity

Exam 2: Alcohol and Smoking as Risk Factors in an Epidemiology Study of Patients With Chronic Pancreatitis

C. MelWilcoxEditor, CME Section

Test ID No.: 0126

Contact Hours: 1.0

Expiration Date: March 31, 2012

Question 1

In the North American Pancreatitis Study Group 2, an etiologic classification was given to each patient. Overall, the most common cause of chronic pancreatitis as provided by the physicians was:

[a]
Alcohol
[b]
Chronic renal disease
[c]
No specific cause (idiopathic)

Question 2

Overall alcohol was found to be the cause of chronic pancreatitis in more than 50% of patients.

[a]
True
[b]
False

Question 3

The most common cause of pancreatitis in women, in contrast to men, was:

[a]
Alcohol
[b]
Obesity
[c]
Pancreas divisum
[d]
Idiopathic

Question 4

Which of the following was significantly higher in the idiopathic chronic pancreatitis patients as compared to the controls?

[a]
Age
[b]
Race
[c]
Ever or current smoker
[d]
At-risk drinking

Front Page